top of page

3rd Round: Community Antibody Test Pilot Scheme


Learning from the experiences of previous programs, we found that some carers are also very concerned about the level of antibodies against COVID-19*. Because if they are unfortunately infected, it must interrupt the care routine, and their loved one may be even left without care. In view of this, in the 3rd round of the program, we further expand the service to carers, so that they can focus on taking care of their loved ones.

Many carers spend too much effort on caring work, lack adequate rest, and neglect their own needs, which affects their physical and mental health. Therefore, we have developed the ”CARER.AI” mobile app, which enables carers to make appointments for their loves at any time, such as escort service, companion service and rehabilitation service, thereby reducing the pressure of care and giving them a chance to relax.




* The Panbio™ COVID-19 IgG Rapid Test Device detects immunoglobulin (IgG) antibodies to the SARS-CoV-2 spike protein receptor binding domain (S1-RBD). This test can identify individuals with prior COVID-19 infection or post vaccination antibodies. This antibody test can help you determine if an individual has developed antibodies post infection and/or post vaccination. Conduct serological surveillance. This is done by taking “snapshots” of the percentage of people who have antibodies against SARS-CoV-2 (also called the seroprevalence) at different time points. This can provide information about antibody trends and help professionals determine the burden of severe disease on the healthcare system. Learn more: https://www.globalpointofcare.abbott/en/product-details/panbio-covid-19-igg-test.html?c=WW

26 views0 comments

Recent Posts

See All

Comentários


bottom of page